开窗与分支腔内主动脉瘤修复术后瘤囊动态变化及其预后意义
该研究纳入2008至2020年间在两个大型血管中心接受开窗或分支腔内主动脉瘤修复术(F/BEVAR)的复杂退行性主动脉瘤患者165例,按术后1年较30天瘤囊体积变化比例(>5%)分为退化组与未退化组。风险校正分析显示,未退化与5年内全因死亡风险升高(HR 2.56)及移植相关事件风险升高(HR 2.44)相关。开窗术后瘤囊多呈退化(1年66%),分支术后1年瘤囊增长比例达28%。
要点
- F/BEVAR术后1年影像未退化与5年全因死亡风险升高相关(HR 2.56)
- F/BEVAR术后1年影像未退化与5年移植相关事件风险升高相关(HR 2.44)
- 开窗术后1年瘤囊退化占66%,分支术后1年瘤囊增长占28%
核心结论
- 与肾下型EVAR类似,F/BEVAR术后1年影像未退化与5年全因死亡及移植相关事件风险升高相关。
- 开窗腔内修复治疗近肾主动脉瘤后瘤囊多呈退化(1年66%),而分支腔内修复治疗胸腹主动脉瘤后1年瘤囊增长比例达28%,可能提示持续破裂风险,需在BEVAR后加强监测。
- 未来研究需阐明如何改善复杂EVAR术后瘤囊退化,以及BEVAR后高扩张风险是否与病变范围广泛有关。
研究设计与样本
- 研究纳入2008至2020年间在两个大型血管中心接受F/BEVAR治疗退行性复杂主动脉瘤、且具有30天和1年两次影像检查的患者。
- 共纳入165例患者,其中开窗腔内主动脉修复(FEVAR)122例,分支腔内主动脉修复(BEVAR)43例。
- 根据1年较30天瘤囊体积变化比例(>5%)将患者分为退化组与未退化组。
- 采用Kaplan-Meier法评估全因死亡率和免于移植相关事件,并分别对FEVAR和BEVAR使用多变量logistic回归和线性混合效应模型分析1年未退化及瘤囊体积随时间变化的相关因素。
主要发现
- FEVAR组122例中34%在1年影像时未退化(20%稳定,14%扩张);BEVAR组43例中53%未退化(26%稳定,28%扩张)。
- 风险校正分析显示,未退化与5年内全因死亡风险升高相关(HR 2.56,95%CI 1.09-5.37;p=0.032)。
- 未退化与5年内移植相关事件风险升高相关(HR 2.44,95%CI 1.10-5.26;p=0.029)。
- 多变量logistic回归显示,既往主动脉修复(OR 2.56,95%CI 1.11-5.96;p=0.029)和较大基线动脉瘤直径(OR/mm 1.04,95%CI 1.00-1.09;p=0.037)与1年未退化相关。
- 吸烟史与未退化呈负相关(OR 0.21,95%CI 0.04-0.96;p=0.045);FEVAR术后瘤囊体积在2年内显著下降(基线267 cm³,95%CI 250-285 vs 2年223 cm³,95%CI 197-248),此后保持不变;BEVAR术后瘤囊体积随时间保持稳定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to assess aneurysm sac dynamics and its prognostic significance following fenestrated and branched endovascular aneurysm repair (F/BEVAR). METHODS: Patients undergoing F/BEVAR for degenerative complex aortic aneurysm from 2008 to 2020 at two large vascular centres with two imaging examinations (30 day and one year) were included. Patients were categorised as regression and non-regression, determined by the proportional volume change (> 5%) at one year compared with 30 days. All cause mortality and freedom from graft related events were assessed using Kaplan-Meier methods. Factors associated with non-regression at one year and aneurysm sac volume over time were examined for FEVAR and BEVAR independently using multivariable logistic regression and linear mixed effects modelling. RESULTS: One hundred and sixty-five patients were included: 122 FEVAR, of whom 34% did not regress at one year imaging (20% stable, 14% expansion); and 43 BEVAR, of whom 53% failed to regress (26% stable, 28% expansion). Following F/BEVAR, after risk adjusted analysis, non-regression was associated with higher risk of all cause mortality within five years (hazard ratio [HR] 2.56, 95% confidence interval [CI] 1.09 - 5.37; p = .032) and higher risk of graft related events within five years (HR 2.44, 95% CI 1.10 - 5.26; p = .029). Following multivariable logistic regression, previous aortic repair (odds ratio [OR] 2.56, 95% CI 1.11 - 5.96; p = .029) and larger baseline aneurysm diameter (OR/mm 1.04, 95% CI 1.00 - 1.09; p = .037) were associated with non-regression at one year, whereas smoking history was inversely associated with non-regression (OR 0.21, 95% CI 0.04 - 0.96; p = .045). Overall following FEVAR, aneurysm sac volume decreased significantly up to two years (baseline vs. two year, 267 [95% CI 250 - 285] cm3vs. 223 [95% CI 197 - 248] cm3), remaining unchanged thereafter. Overall following BEVAR, aneurysm sac volume remained stable over time. CONCLUSION: Like infrarenal EVAR, non-regression at one year imaging is associated with higher five year all cause mortality and graft related events risks after F/BEVAR. Following FEVAR for juxtarenal aortic aneurysm, aneurysm sacs generally displayed regression (66% at one year), whereas after BEVAR for thoraco-abdominal aortic aneurysm, aneurysm sacs displayed a concerning proportion of growth at one year (28%), potentially suggesting a persistent risk of rupture and consequently requiring intensified surveillance following BEVAR. Future studies will have to elucidate how to improve sac regression following complex EVAR, and whether the high expansion risk after BEVAR is due to advanced disease extent.
引用
- Rastogi V, Sulzer TAL, de Bruin JL, et al. Aneurysm Sac Dynamics and its Prognostic Significance Following Fenestrated and Branched Endovascular Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg. 2023. PMID: 37995962. doi:10.1016/j.ejvs.2023.11.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。